Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contoura Topography-guided Ablation Versus Wavefront-optimized Ablation for Correction of Astigmatism

NCT05829980 is registered in ClinicalTrials.gov with Hebatallah MT Abdelmoniem as lead sponsor.

NCT NCT05829980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05829980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contoura Topography-guided Ablation Versus Wavefront-optimized Ablation for Correction of Astigmatism
Lead sponsor
Hebatallah MT Abdelmoniem
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2023
Completion date
April 30, 2025
Enrollment
128 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

astigmatism